Clinical trial
Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
NCT00457808 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00457808 |
|---|---|
| Title | Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM |
| Official title | Rapamycin Therapy of Angiomyolipomas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | The LAM Foundation Tuberous Sclerosis Alliance |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tuberous Sclerosis, Lymphangioleiomyomatosis |
| Intervention type | Drug |
| Interventions | Rapamycin, sirolimus |
| Enrollment | 25 |
| Start date | Dec 1, 2002 |
| Completion | Mar 1, 2006 |
| First posted | Apr 9, 2007 |
| Last update posted | Apr 9, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: